Tower Research Capital LLC (TRC) - OSMOTICA PHARMACEUTICALS PLC ownership

OSMOTICA PHARMACEUTICALS PLC's ticker is OSMT and the CUSIP is G6S41R101. A total of 3 filers reported holding OSMOTICA PHARMACEUTICALS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of OSMOTICA PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$2,862
+6.9%
32,898
+588.2%
0.00%
Q2 2023$2,677
+89133.3%
4,780
+80.7%
0.00%
Q1 2023$3
-100.0%
2,645
-82.9%
0.00%
-100.0%
Q3 2022$32,000
+540.0%
15,483
+412.3%
0.00%
Q1 2022$5,000
+150.0%
3,022
+79.3%
0.00%
Q4 2021$2,000
-91.3%
1,685
-78.5%
0.00%
-100.0%
Q3 2021$23,000
+15.0%
7,848
+16.1%
0.00%0.0%
Q2 2021$20,000
-62.3%
6,762
-58.0%
0.00%0.0%
Q1 2021$53,000
+231.2%
16,116
+315.0%
0.00%
Q4 2020$16,000
-55.6%
3,883
-41.2%
0.00%
Q3 2020$36,000
+9.1%
6,601
+33.0%
0.00%
-100.0%
Q2 2020$33,0004,963
+2187.1%
0.00%
Q1 2020$0
-100.0%
217
-98.1%
0.00%
-100.0%
Q4 2019$79,000
+119.4%
11,218
+18.7%
0.01%
+250.0%
Q3 2019$36,000
+1700.0%
9,454
+1412.6%
0.00%
Q2 2019$2,000
-85.7%
625
-84.4%
0.00%
-100.0%
Q1 2019$14,000
-12.5%
4,017
+88.9%
0.00%0.0%
Q4 2018$16,0002,1270.00%
Other shareholders
OSMOTICA PHARMACEUTICALS PLC shareholders Q4 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,500,000$11,625,0001.47%
JW Asset Management, LLC 225,000$1,744,0001.28%
Sio Capital Management, LLC 346,410$2,685,0000.98%
Endurant Capital Management LP 232,048$1,798,0000.95%
SPHERA FUNDS MANAGEMENT LTD. 922,200$7,147,0000.81%
Broadfin Capital, LLC 528,571$4,096,0000.54%
NEXTHERA CAPITAL LP 120,620$935,0000.38%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,138,256$8,821,0000.35%
Sofinnova Investments, Inc. 253,089$1,961,0000.24%
MILLENNIUM MANAGEMENT LLC 331,332$2,568,0000.00%
View complete list of OSMOTICA PHARMACEUTICALS PLC shareholders